01 1Chromo Laboratories
01 1OLANZAPINE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2026-01-09
Pay. Date : 2025-11-21
DMF Number : 33221
Submission : 2022-07-15
Status : Active
Type : II
20
Chromo Laboratories India Private Ltd, based in India, is a pharmaceutical company.
One of their notable products is OLANZAPINE USP, with a corresponding US DMF Number 33221.
Remarkably, this DMF maintains an Active status since its submission on July 15, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 09, 2026, and payment made on November 21, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
